The Legal 500

Twitter Logo Youtube Circle Icon LinkedIn Icon

DLA Piper LLP (US)

4365 EXECUTIVE DRIVE, SUITE 1100, SAN DIEGO, CA 92121-2133, USA
Tel:
Work +1 858 677 1400
Fax:
Fax +1 858 677 1401
Web:
www.dlapiper.com

Mark Lehberg

Tel:
Work +1 858 677 1419
Email:
Web:
www.dlapiper.com/en/us/people/l/lehberg-mark-c/
DLA Piper LLP (US)

Work Department

Intellectual Property and Technology; Corporate; Trademark and Copyright; Mergers and Acquisitions; Emerging Growth and Venture Capital; Technology Transactions and Strategic Sourcing; Life Sciences; Technology; Industrials; Energy and Natural Resources; Media, Sport and Entertainment

Position

Partner

Career

Mark Lehberg focuses his practice in the area of business and legal counseling in connection with complex business and technology related transactions, including outsourcing transactions, cloud computing and software as a service (SaaS), intellectual property license agreements, strategic alliances, joint research and development agreements, joint ventures and other commercial transactions involving intellectual property assets.

Mark also works with clients to identify and develop creative solutions for managing key risk allocation issues in complex business and technology related transactions. He advises large public companies, startup companies and nonprofit companies in the development of intellectual property strategies, including strategies for the protection, licensing and other exploitation of intellectual property assets.

Education

J.D., Wake Forest University; M.B.A., University of Rochester; B.A., University of San Diego


United States: Intellectual property

Patents: licensing

Within: Patents: licensing

DLA Piper LLP (US) delivers 'first class service' and offers 'a one-stop shop for all legal needs', thanks to the 'impressive scope of its US and international practice'. The group fields a strong transactional practice, but also excels in commercial licencing agreements and litigation settlements. Technology-related mandates account for the majority of recent highlight matters, but the group was also active for life sciences, automotive, retail and energy clients. Clients include Qualcomm, the University of Texas at Austin and Revolution Contraceptive. Practice head Mark Lehberg in San Diego, 'exceptional IP attorney' Jeffrey Aronson and Victoria Lee in Silicon Valley, and Philadelphia's Darius Gambino form the heart of the practice. Silicon Valley's Tzung-Bor Wei made partner. Michael McGurk left to found McGurk Group LLC. John Garvey joined Noria Therapeutics and Shane Albright joined Goodwin.

[back to top]

United States: M&A/corporate and commercial

Commercial deals and contracts

Within: Commercial deals and contracts

DLA Piper LLP (US) is instructed primarily by clients in the technology and software industries, which it advises on a range of commercial transactions including tech licensing, trade mark agreements and outsourcing deals. Rated by clients for his ‘clearly superior and absolutely outstanding work’, Jeffrey Aronson in Silicon Valley advised Softbank Group Corporation on its investment in the on-demand dog walking service Wag and the messaging app Slack. In addition, the team acted for Nike in relation to its acquisition of artificial intelligence company Invertex. Other key figures include joint practice heads Mark Lehberg in Sand Diego and Richard Greenstein in Atlanta. The firm also saw a number of personnel changes in 2018: Washington DC-based Margo Tank and Chicago-based David Whitaker joined the practice group from Buckley LLP, and Matthew Gruenberg joined the Los Angeles office from Barnes & Thornburg LLP; Ryan T. Sulkin left the firm for Michael, Best & Friedrich LLP.

[back to top]


Back to index

Legal Developments by:
DLA Piper LLP (US)

  • Sentencing guidelines for corporate manslaughter

    In February 2010 the Sentencing Guidelines Council (the SGC) issued definitive guidelines to courts on imposing appropriate sentences for corporate manslaughter and health and safety offences causing death. The SGC states that fines imposed on companies found guilty of corporate manslaughter should not fall below £500,000, while fines in respect of health and safety offences that are a significant cause of death should be at least £100,000. Crucially, the SGC declined to provide for a fixed link between the imposed fine and the turnover or profitability of the offending company.

    - DLA Piper UK LLP

Legal Developments worldwide

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to